Now PlayingEP. 1 Geriatric Diabetes Care: Optimizing Type 2 Diabetes Management Insights from Dr. John Anderson
EP. 4 Patient Case 2: Exploring the Advantages of Combination Therapy in T2D and Addressing Affordability and Access Issues
EP. 6 Evolving Diabetes Care: Strategic Adjustments and Combination Therapy Benefits for Older Adults
EP. 7 Refining Treatment Protocols: Expert Perspectives on Deprescribing and Streamlining Diabetes Care for Older Adults
October 6th, 20269 Drugs Approved for Primary Care: Q3 2026Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.Read more
September 24th, 2026FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 DiabetesThe FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes. Read more
September 23rd, 2026Type 2 Diabetes, Genetic Risk Linked to MASLD Cirrhosis Before Age 50New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.Read more
September 17th, 2026FDA Approves Finerenone for CKD Associated With Type 1 DiabetesFinerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.Read more